The present study included women who had a cytohistological diagnosis of their lesions prior to the treatment, were treated at least six months before, and had an updated cytological diagnosis performed after the treatment, when the HR-HPV was detected by the HC-IIâ test.
En el presente estudio se incluyeron mujeres que contaron con un diagnóstico cito-histológico de la lesión previo al tratamiento, que fueron tratadas con una antecedencia de al menos 6 meses y que posterior al tratamiento contaron con un diagnóstico citológico actualizado al momento de realizarse la detección de HR-HPV por CH II.